K. Rivet Amico, PhD
About K. Rivet Amico, PhD
Rivet is a research scientist at the University of Connecticut’s Center for Health, Innovation, and Prevention, and also works with Applied Health Research as a developer and trainer of interventions that use communication and counseling theory to support adherence and retention in the context of clinical trials and resource limited settings.
Methodology, design, measurement, and analytic strategies in cross-sectional and longitudinal designs are also of interest. The development of interventions to support medication and treatment adherence that are ecologically valid, culturally competent, and highly translatable to practical settings guides much of my research and project development to date. As a co-developer of the IMB-model of HAART adherence and the developer of the situated-Information Motivation Behavioral Skills model of care initiation and maintenance (sIMB-CIM), Rivey firmly believes in the potential contributions that theorists and methodologists can make in efforts to promote health behavior. The intersection between medicine, behavioral science, and systems of care offers the unique opportunity for health psychologists to actively contribute to multidisciplinary teams and shape the direction of behavioral interventions for promotion of health and clinical outcomes for those struggling with chronic medical conditions. This is particularly the case in HIV care, as this cohort is aging and the proportion of those dealing with co-morbities continues to increase. Similarly, in areas where diet and lifestyle are the targets of recommended treatment, sophisticated strategies for supporting engagement in care must address broad compendiums of treatment recommendations and not just adherence to medication. It is in these areas that my program of research seeks to develop and evaluate comprehensive models and model-based interventions.
Role(s) / Profession(s)
- Researcher
Organization
- University of Connecticut
Work Location(s)
- United States
Language(s)
- English
- French
K. Rivet's Communities
- Moderator [ARCHIVED] Adherence & Retention
- [ARCHIVED] HIV Prevention
- Moderator HIV Treatment & Prevention
Recent Contributions
-

K. Rivet Amico, PhD replied to "Functional Cure News and Adherence" in the HIV Treatment & Prevention community.
I really hope you are right about people working closely with their provider and weighing the evidence. However, logic does not always drive behavior...actually- not true- most people have perfectly sound logic from their perspective driving a course of action but it just is not necessarily "our logic." Your point ...
-

K. Rivet Amico, PhD replied to "Functional Cure News and Adherence" in the HIV Treatment & Prevention community.
Thanks so much for the added insights on this issue. Rivet
-

K. Rivet Amico, PhD started a discussion "Functional Cure News and Adherence". in the HIV Treatment & Prevention community.
With news coming out every day about 'functional cure' of HIV (see http://www.cnn.com/2013/03/18/health/hiv-functional-cure/ for example)- I was wondering if anyone in the community has been approached by patients interested in finding out if they are functionally cured. Has anyone encountered this? Obviously, my concern is around people stopping ART without ...
-

K. Rivet Amico, PhD replied to "Dissemination of research findings to HIV research participants" in the HIV Treatment & Prevention community.
Excellent! I found the careful attention to cultural context and blending of research and local culture in a systematic way really insightful. The steps are a useful map for many different projects. Thanks for sharing this! Rivet
-

K. Rivet Amico, PhD replied to "Long acting antiretroviral medications for treatment and prevention" in the HIV Treatment & Prevention community.
There are a number of studies looking into intermittent PrEP schedules and results should be available soon on rates of adherence relative to fixed dose and sex-dependent dosing. While not with long acting agents, these results should provide some information about general adherence to non-daily schedules of drug taking. I ...
Recent Recommendations
-

K. Rivet Amico, PhD recommended "Dose Removal Medication Monitors (posted for Dr. Tom Moulding)" in the community.
-

-

K. Rivet Amico, PhD recommended "panel-discussion" in the community.
